Status:

COMPLETED

Minocycline as an Adjunct for the Treatment of Depressive Symptoms: Pilot Randomized Controlled Trial

Lead Sponsor:

Pakistan Institute of Living and Learning

Collaborating Sponsors:

King's College London

Conditions:

Depressive Disorder

Mood Disorders

Eligibility:

All Genders

18-65 years

Phase:

PHASE4

Brief Summary

In this double blind randomised controlled pilot trial the investigators aim to determine the efficacy of minocycline as an adjunct to treatment as usual in patients with major depressive disorder. Th...

Detailed Description

Major depressive disorder is associated with significant morbidity and mortality. According to the WHO, depression is the leading cause of disability worldwide in terms of years lost due to disability...

Eligibility Criteria

Inclusion

  • patients aged 18-65 years
  • Diagnostic and Statistical Manual-IV (DSM-IV) diagnosis of major depressive disorder
  • competent and willing to give informed consent
  • taking the current antidepressant medication for a minimum of 4 weeks prior to baseline
  • the current episode of depression has failed to remit with at least two courses of antidepressant treatment (one of which is the current course)
  • able to take oral medication
  • if female, willing to use adequate contraceptive precautions and to have monthly pregnancy tests.

Exclusion

  • relevant medical illness (renal, hepatic, cardiac, serious dermatological disorders such as exfoliative dermatitis, systemic lupus erythematosis)
  • prior history of intolerance to any of the tetracyclines
  • concomitant penicillin therapy
  • concomitant anticoagulant therapy
  • presence of a seizure disorder
  • currently taking valproic acid
  • any change of psychotropic medications within the previous 4 weeks
  • diagnosis of substance abuse (except nicotine or caffeine) or dependence within the last 3 months according to DSM-IV criteria
  • pregnant or breast-feeding
  • presence of primary psychotic disorder.

Key Trial Info

Start Date :

October 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2016

Estimated Enrollment :

41 Patients enrolled

Trial Details

Trial ID

NCT02263872

Start Date

October 1 2014

End Date

August 1 2016

Last Update

September 5 2016

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Abasi Shaheed Hospital

Karachi, Sindh, Pakistan, 72000

2

Civil hospital Karachi

Karachi, Sindh, Pakistan, 72000

3

Karwan-e-Hayat

Karachi, Sindh, Pakistan